계산
총 자산 회전율 | = | 물품 판매1 | ÷ | 총 자산1 | |
---|---|---|---|---|---|
2024. 12. 31. | 0.48 | = | 28,610) | ÷ | 58,995) |
2023. 12. 31. | 0.43 | = | 26,934) | ÷ | 62,125) |
2022. 12. 31. | 0.43 | = | 26,982) | ÷ | 63,171) |
2021. 12. 31. | 0.40 | = | 27,008) | ÷ | 67,952) |
2020. 12. 31. | 0.36 | = | 24,355) | ÷ | 68,407) |
2019. 12. 31. | 0.36 | = | 22,119) | ÷ | 61,627) |
2018. 12. 31. | 0.34 | = | 21,677) | ÷ | 63,675) |
2017. 12. 31. | 0.37 | = | 25,662) | ÷ | 70,283) |
2016. 12. 31. | 0.53 | = | 29,953) | ÷ | 56,977) |
2015. 12. 31. | 0.62 | = | 32,151) | ÷ | 51,839) |
2014. 12. 31. | 0.71 | = | 24,474) | ÷ | 34,664) |
2013. 12. 31. | 0.48 | = | 10,804) | ÷ | 22,497) |
2012. 12. 31. | 0.44 | = | 9,398) | ÷ | 21,240) |
2011. 12. 31. | 0.47 | = | 8,102) | ÷ | 17,303) |
2010. 12. 31. | 0.64 | = | 7,390) | ÷ | 11,593) |
2009. 12. 31. | 0.67 | = | 6,469) | ÷ | 9,699) |
2008. 12. 31. | 0.72 | = | 5,085) | ÷ | 7,019) |
2007. 12. 31. | 0.64 | = | 3,733) | ÷ | 5,835) |
2006. 12. 31. | 0.63 | = | 2,588) | ÷ | 4,086) |
2005. 12. 31. | 0.48 | = | 1,809) | ÷ | 3,765) |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
Gilead Sciences Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024. 12. 31. | 0.48 | 0.42 | 0.35 | 0.52 | 0.31 | 0.57 | 0.49 | 0.55 | 0.30 | 0.38 | 0.44 | 0.49 |
2023. 12. 31. | 0.43 | 0.40 | 0.28 | 0.47 | 0.28 | 0.53 | 0.51 | 0.56 | 0.26 | 0.40 | 0.43 | 0.43 |
2022. 12. 31. | 0.43 | 0.42 | 0.38 | 0.48 | 0.37 | 0.58 | 0.51 | 0.54 | 0.51 | 0.42 | 0.46 | 0.49 |
2021. 12. 31. | 0.40 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.52 | 0.46 | 0.45 | 0.63 | 0.41 | 0.56 |
2020. 12. 31. | 0.36 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.47 | 0.52 | 0.28 | 0.50 | 0.47 | 0.53 |
2019. 12. 31. | 0.36 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 | 0.50 |
2018. 12. 31. | 0.34 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 | 0.49 |
2017. 12. 31. | 0.37 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.49 | 0.46 | 0.31 | 0.67 | 0.37 | 0.70 |
2016. 12. 31. | 0.53 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.51 | 0.42 | 0.31 | 0.70 | 0.40 | 0.59 |
2015. 12. 31. | 0.62 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.53 | 0.39 | 0.29 | 0.73 | 0.41 | 0.41 |
2014. 12. 31. | 0.71 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.57 | 0.43 | 0.29 | 0.73 | 0.39 | 0.25 |
2013. 12. 31. | 0.48 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.54 | 0.42 | 0.30 | 0.71 | 0.41 | 0.52 |
2012. 12. 31. | 0.44 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.55 | 0.45 | 0.32 | 0.66 | 0.46 | 0.55 |
2011. 12. 31. | 0.47 | — | 0.31 | 0.64 | 0.54 | 0.72 | 0.57 | 0.46 | 0.36 | 0.34 | 0.44 | 0.64 |
2010. 12. 31. | 0.64 | — | 0.34 | 0.63 | 0.59 | 0.74 | 0.60 | 0.43 | 0.35 | 0.42 | 0.51 | 0.08 |
2009. 12. 31. | 0.67 | — | 0.36 | 0.61 | 0.57 | 0.80 | 0.65 | 0.24 | 0.23 | 0.51 | 0.47 | 0.05 |
2008. 12. 31. | 0.72 | — | 0.40 | 0.70 | 0.73 | 0.70 | 0.75 | 0.51 | 0.43 | 0.36 | 0.50 | 0.18 |
2007. 12. 31. | 0.64 | — | 0.41 | 0.74 | 0.63 | 0.70 | 0.75 | 0.50 | 0.42 | 0.13 | 0.46 | 0.33 |
2006. 12. 31. | 0.63 | — | 0.41 | 0.70 | 0.75 | 0.71 | 0.76 | 0.51 | 0.42 | 0.11 | 0.18 | 0.23 |
2005. 12. 31. | 0.48 | — | 0.41 | 0.68 | 0.87 | 0.60 | 0.87 | 0.49 | 0.44 | 0.16 | 0.62 | 0.29 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Gilead Sciences Inc. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2024. 12. 31. | 0.48 | 0.43 |
2023. 12. 31. | 0.43 | 0.40 |
2022. 12. 31. | 0.43 | 0.47 |
2021. 12. 31. | 0.40 | 0.45 |
2020. 12. 31. | 0.36 | 0.39 |
2019. 12. 31. | 0.36 | 0.39 |
2018. 12. 31. | 0.34 | 0.45 |
2017. 12. 31. | 0.37 | 0.40 |
2016. 12. 31. | 0.53 | 0.41 |
2015. 12. 31. | 0.62 | 0.42 |
2014. 12. 31. | 0.71 | 0.44 |
2013. 12. 31. | 0.48 | 0.43 |
2012. 12. 31. | 0.44 | 0.45 |
2011. 12. 31. | 0.47 | 0.47 |
2010. 12. 31. | 0.64 | 0.47 |
2009. 12. 31. | 0.67 | 0.39 |
2008. 12. 31. | 0.72 | 0.57 |
2007. 12. 31. | 0.64 | 0.56 |
2006. 12. 31. | 0.63 | 0.54 |
2005. 12. 31. | 0.48 | 0.57 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Gilead Sciences Inc. | 의료 | |
---|---|---|
2024. 12. 31. | 0.48 | 0.75 |
2023. 12. 31. | 0.43 | 0.73 |
2022. 12. 31. | 0.43 | 0.75 |
2021. 12. 31. | 0.40 | 0.70 |
2020. 12. 31. | 0.36 | 0.64 |
2019. 12. 31. | 0.36 | 0.65 |
2018. 12. 31. | 0.34 | 0.68 |
2017. 12. 31. | 0.37 | 0.66 |
2016. 12. 31. | 0.53 | 0.67 |
2015. 12. 31. | 0.62 | 0.64 |
2014. 12. 31. | 0.71 | 0.69 |
2013. 12. 31. | 0.48 | 0.67 |
2012. 12. 31. | 0.44 | 0.67 |
2011. 12. 31. | 0.47 | 0.69 |
2010. 12. 31. | 0.64 | 0.68 |
2009. 12. 31. | 0.67 | 0.63 |
2008. 12. 31. | 0.72 | 0.80 |
2007. 12. 31. | 0.64 | 0.77 |
2006. 12. 31. | 0.63 | 0.74 |
2005. 12. 31. | 0.48 | 0.72 |
보고서 기준: 10-K (보고 날짜: 2024-12-31), 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).